Diabetic Retinopathy: Animal Models, Therapies, and Perspectives

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Cai, Xue ^a   McGinnis, James F ^a,b  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AFLIBERCEPT; BEVACIZUMAB; FENOFIBRATE; MICRORNA; OMEGA 3 FATTY ACID; RANIBIZUMAB; REACTIVE OXYGEN METABOLITE; SOMATOMEDIN BINDING PROTEIN 3; UNTRANSLATED RNA; SIRTUIN 1; TUMOR NECROSIS FACTOR;

AKIMBA MOUSE; AKITA MOUSE; ANIMAL MODEL; B SCAN; BLOOD RETINA BARRIER; CHINESE MEDICINE; DB/DB MOUSE; DIABETIC MACULAR EDEMA; DIABETIC RETINOPATHY; EPIGENETICS; FLUORESCENCE ANGIOGRAPHY; HUMAN; HYPERGLYCEMIA; HYPOINSULINEMIA; INSULIN DEPENDENT DIABETES MELLITUS; KIMBA MOUSE; MICROVASCULATURE; MOLECULAR PATHOLOGY; MUTANT MOUSE STRAIN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PERICYTE; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RETINA DEGENERATION; RETINA NEOVASCULARIZATION; REVIEW; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; SUBRETINAL NEOVASCULARIZATION; TRANSGENIC MOUSE; ANIMAL; ANTAGONISTS AND INHIBITORS; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; MOUSE; PHYSIOLOGY; STEM CELL TRANSPLANTATION;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; HUMANS; MICE; SIRTUIN 1; STEM CELL TRANSPLANTATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84955603805     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/3789217     Document Type: Review

References (99)

1. C.-M. Lai, S. A. Dunlop, L. A. May et al., "Generation of trans-genic mice with mild and severe retinal neovascularisation, " British Journal of Ophthalmology, vol. 89, no. 7, pp. 911-916, 2005.
2. N. Cheung, P. Mitchell, and T. Y. Wong, "Diabetic retinopathy, " The Lancet, vol. 376, no. 9735, pp. 124-136, 2010.
3. R. Robinson, V. A. Barathi, S. S. Chaurasia, T. Y. Wong, and T. S. Kern, "Update on animal models of diabetic retinopathy: from molecular approaches to mice and higher mammals, " Disease Models and Mechanisms, vol. 5, no. 4, pp. 444-456, 2012.
4. D. A. Salz and A. J. Witkin, "Imaging in diabetic retinopathy, " Middle East African Journal of Ophthalmology, vol. 22, no. 2, pp. 145-150, 2015.
5. A. M. Abu El-Asrar, L. Dralands, L. Missotten, I. A. Al-Jadaan, and K. Geboes, "Expression of apoptosis markers in the retinas of human subjects with diabetes, " Investigative Ophthalmology and Visual Science, vol. 45, no. 8, pp. 2760-2766, 2004.
6. A. J. Barber, E. Lieth, S. A. Khin, D. A. Antonetti, A. G. Buchanan, and T. W. Gardner, "Neural apoptosis in the retina during experimental and human diabetes. Early onset and efect of insulin, " The Journal of Clinical Investigation, vol. 102, no. 4, pp. 783-791, 1998.
7. M. S. Ola and A. S. Alhomida, "Neurodegeneration in diabetic retina and its potential drug targets, " Current Neuropharmacol-ogy, vol. 12, no. 4, pp. 380-386, 2014.
8. J. S. Ng, M. A. Bearse Jr., M. E. Schneck, S. Barez, and A. J. Adams, "Local diabetic retinopathy prediction by multifocal ERG delays over 3 years, " Investigative Ophthalmology and Visual Science, vol. 49, no. 4, pp. 1622-1628, 2008.
9. A. J. Barber, "Diabetic retinopathy: recent advances towards understanding neurodegeneration and vision loss, " Science China Life Sciences, vol. 58, no. 6, pp. 541-549, 2015.
10. R. Mastropasqua, L. Toto, F. Cipollone, D. Santovito, P. Carpineto, and L. Mastropasqua, "Role of microRNAs in the modulation of diabetic retinopathy, " Progress in Retinal and Eye Research, vol. 43, pp. 92-107, 2014.
11. A. Das, P. G. McGuire, and S. Rangasamy, "Diabetic macular edema: pathophysiology and novel therapeutic targets, " Ophthalmology, vol. 122, no. 7, pp. 1375-1394, 2015.
12. H.-P. Hammes, Y. Feng, F. Pfster, and M. Brownlee, "Diabetic retinopathy: targeting vasoregression, " Diabetes, vol. 60, no. 1, pp. 9-16, 2011.
13. D. A. Antonetti, A. J. Barber, S. Khin, E. Lieth, J. M. Tarbell, and T. W. Gardner, "Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group, " Diabetes, vol. 47, no. 12, pp. 1953-1959, 1998.
14. J. M. Tarr, K. Kaul, M. Chopra, E. M. Kohner, and R. Chibber, "Pathophysiology of diabetic retinopathy, " ISRN Ophthalmology, vol. 2013, Article ID 343560, 13 pages, 2013.
15. A. M. Joussen, V. Poulaki, M. L. Le et al., "A central role for infammation in the pathogenesis of diabetic retinopathy, " The FASEB Jour nal, vol. 18, no. 12, pp. 1450-1452, 2004.
16. F. Semeraro, A. Cancarini, R. dell'Omo, S. Rezzola, M. R. Romano, and C. Costagliola, "Diabetic retinopathy: vascular and infammatory disease, " Journal of Diabetes Research, vol. 2015, Article ID 582060, 16 pages, 2015.
17. E. C. Leal, A. Manivannan, K.-I. Hosoya et al., "Inducible nitric oxide synthase isoform is a key mediator of leukostasis and blood-retinal barrier breakdown in diabetic retinopathy, " Investigative Ophthalmology and Visual Science, vol. 48, no. 11, pp. 5257-5265, 2007.
18. H. Vorum and J. Ditzel, "Disturbance of inorganic phosphate metabolism in diabetes mellitus: its relevance to the pathogene-sis of diabetic retinopathy, " Journal of Ophthalmology, vol. 2014, Article ID 135287, 8 pages, 2014.
19. A.Das, S.Stroud, A.Mehta, andS.Rangasamy, "New treatments for diabetic retinopathy, " Diabetes, Obesity and Metabolism, vol. 17, no. 3, pp. 219-230, 2015.
20. Q. Lu, L. Lu, W. Chen, H. Chen, X. Xu, and Z. Zheng, "RhoA/mDia-1/proflin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy, " Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 253, no. 5, pp. 669-680, 2015.
21. Q. Y. Lu, W. Chen, L. Lu et al., "Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathy, " International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 7268-7277, 2014.
22. T. Oshitari, N. Hata, and S. Yamamoto, "Endoplasmic reticulum stress and diabetic retinopathy, " Vascular Health and Risk Management, vol. 4, no. 1, pp. 115-122, 2008.
23. Z. H. Tang, L. Wang, F. Zeng, and K. Zhang, "Human genetics of diabetic retinopathy, " Journal of Endocrinological Investigation, vol. 37, no. 12, pp. 1165-1174, 2014.
24. M. A. Reddy, E. Zhang, and R. Natarajan, "Epigenetic mechanisms in diabetic complications and metabolic memory, " Diabetologia, vol. 58, no. 3, pp. 443-455, 2015.
25. L. Perrone, C. Matrone, and L. P. Singh, "Epigenetic modifca-tions and potential new treatment targets in diabetic retinopa-thy, " Journal of Ophthalmology, vol. 2014, Article ID 789120, 10 pages, 2014.
26. F. A. A. Kwa and T. R. Trimawithana, "Epigenetic modif-cations as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy, " Drug Discovery Today, vol. 19, no. 9, pp. 1387-1393, 2014.
27. B. M. Braunger, S. V. Leimbeck, A. Schlecht, C. Volz, H. Jägle, and E. R. Tamm, "Deletion of ocular transforming growth factor? signaling mimics essential characteristics of diabetic retinopathy, " The American Journal of Pathology, vol. 185, no. 6, pp. 1749-1768, 2015.
28. K. A. Hussein, K. Choksi, S. Akeel et al., "Bone morphogenetic protein 2: a potential new player in the pathogenesis of diabetic retinopathy, " Experimental Eye Research, vol. 125, pp. 79-88, 2014.
29. H. Wang, H. Shi, J. Zhang et al., "Toll-like receptor 4 in bone marrow-derived cells contributes to the progression of diabetic retinopathy, " Mediators of Infammation, vol. 2014, Article ID 858763, 7 pages, 2014.
30. T. Sugiyama, "Role of P2X7 receptors in the development of diabetic retinopathy, " Wo r l d J o u r n a l o f D i a b e t e s, vol. 5, no. 2, pp. 141-145, 2014.
31. L. P. Singh, "Tioredoxin interacting protein (TXNIP) and pathogenesis of diabetic retinopathy, " Journal of Clinical & Experimental Ophthalmology, vol. 4, 2013.
32. C. D. A. Stehouwer, J. Lambert, A. J. M. Donker, and V. W. M. Van Hinsbergh, "Endothelial dysfunction and pathogenesis of diabetic angiopathy, " Cardiovascular Research, vol. 34, no. 1, pp. 55-68, 1997.
33. M. Brownlee, "Biochemistry and molecular cell biology of diabetic complications, " Nature, vol. 414, no. 6865, pp. 813-820, 2001.
34. X. Jiang, L. Yang, and Y. Luo, "Animal models of diabetic retinopathy, " Current Eye Research, vol. 40, no. 8, pp. 761-771, 2015.
35. A. K. W. Lai and A. C. Y. Lo, "Animal models of diabetic retinopathy: summary and comparison, " Journal of Diabetes Research, vol. 2013, Article ID 106594, 29 pages, 2013.
36. M. Yoshioka, T. Kayo, T. Ikeda, and A. Koizumi, "A novel locus, Mody4, distal to D7Mit189 on chromosome 7 determines early-onset NIDDM in nonobese C57BL/6 (Akita) mutant mice, " Diabetes, vol. 46, no. 5, pp. 887-894, 1997.
37. A. J. Barber, D. A. Antonetti, T. S. Kern et al., "The Ins2Akita mouse as a model of early retinal complications in diabetes, " Investigative Ophthalmology & Visual Science, vol. 46, no. 6, pp. 2210-2218, 2005.
38. M. J. Gastinger, A. R. Kunselman, E. E. Conboy, S. K. Bronson, and A. J. Barber, "Dendrite remodeling and other abnormalities in the retinal ganglion cells of Ins2Akita diabetic mice, " Investigative Ophthalmology and Visual Science, vol. 49, no. 6, pp. 2635-2642, 2008.
39. J. R. Hombrebueno, M. Chen, R. G. Penalva, and H. Xu, "Loss of synaptic connectivity, particularly in second order neurons is a key feature of diabetic retinal neuropathy in the Ins2Akita mouse, " PLoS ONE, vol. 9, no. 5, Article ID e97970, 2014.
40. Y. Ha, Y. Dun, M. Tangaraju et al., "Sigma receptor 1 modulates endoplasmic reticulum stress in retinal neurons, " Investigative Ophthalmology and Visual Science, vol. 52, no. 1, pp. 527-540, 2011.
41. J. Wang, T. Takeuchi, S. Tanaka et al., "A mutation in the insulin 2 gene induces diabetes with severe pancreatic?-cell dysfunction in the Mody mouse, " The Journal of Clinical Investigation, vol. 103, no. 1, pp. 27-37, 1999.
42. E. P. Rakoczy, I. S. Ali Rahman, N. Binz et al., "Characterization of a mouse model of hyperglycemia and retinal neovascular-ization, " The American Journal of Pathology, vol. 177, no. 5, pp. 2659-2670, 2010.
43. J. Wisniewska-Kruk, I. Klaassen, I. M. C. Vogels et al., "Molecular analysis of blood-retinal barrier loss in the Akimba mouse, a model of advanced diabetic retinopathy, " Experimental Eye Research, vol. 122, pp. 123-131, 2014.
44. P. Bogdanov, L. Corraliza, J. A. Villena et al., "The db/db mouse: a useful model for the study of diabetic retinal neurodegenera-tion, " PLoS ONE, vol. 9, no. 5, Article ID e97302, 2014.
45. I. S. Samuels, B. A. Bell, A. Pereira, J. Saxon, and N. S. Peachey, "Early retinal pigment epithelium dysfunction is concomitant with hyperglycemia in mouse models of type 1 and type 2 diabetes, " Journal of Neurophysiology, vol. 113, no. 4, pp. 1085-1099, 2015.
46. A. K. H. Cheung, M. K. L. Fung, A. C. Y. Lo et al., "Aldose reductase defciency prevents diabetes-induced blood-retinal barrier breakdown, apoptosis, and glial reactivation in the retina of db/db mice, " Diabetes, vol. 54, no. 11, pp. 3119-3125, 2005.
47. A. Ly, M. F. Scheerer, S. Zukunf et al., "Retinal proteome alterations in a mouse model of type 2 diabetes, " Diabetologia, vol. 57, no. 1, pp. 192-203, 2014.
48. D. M. Sherry, M. M. Wang, J. Bates, and L. J. Frishman, "Expression of vesicular glutamate transporter 1 in the mouse retina reveals temporal ordering in development of rod vs. cone and ON vs. OFF circuits, " Journal of Comparative Neurology, vol. 465, no. 4, pp. 480-498, 2003.
49. P. Villacampa, V. Haurigot, and F. Bosch, "Proliferative retinopathies: animal models and therapeutic opportunities, " Current Neurovascular Research, vol. 12, no. 2, pp. 189-198, 2015.
50. J. Ruberte, E. Ayuso, M. Navarro et al., "Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease, " The Journal of Clinical Investigation, vol. 113, no. 8, pp. 1149-1157, 2004.
51. P. Villacampa, A. Ribera, S. Motas et al., "Insulin-like growth factor I (IGF-I)-induced chronic gliosis and retinal stress lead to neurodegeneration in a mouse model of retinopathy, " The Journal of Biological Chemistry, vol. 288, no. 24, pp. 17631-17642, 2013.
52. A. Chronopoulos, S. Roy, E. Beglova, K. Mansfeld, L. Wacht-man, and S. Roy, "Hyperhexosemia-induced retinal vascular pathology in a novel primate model of diabetic retinopathy, " Diabetes, vol. 64, no. 7, pp. 2603-2608, 2015.
53. P. Osaadon, X. J. Fagan, T. Lifshitz, and J. Levy, "A review of anti-VEGF agents for proliferative diabetic retinopathy, " Eye, vol. 28, no. 5, pp. 510-520, 2014.
54. J. A. Wells, A. R. Glassman, A. R. Ayala et al., "Afibercept, bevacizumab, or ranibizumab for diabetic macular edema, " The New England Journal of Medicine, vol. 372, no. 13, pp. 1193-1203, 2015.
55. M. J. Elman, A. Ayala, N. M. Bressler et al., "Intravitreal Ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: 5-year randomized trial results, " Ophthalmology, vol. 122, no. 2, pp. 375-381, 2015.
56. S. B. Bressler, T. Almukhtar, A. Bhorade et al., "Repeated intrav-itreous ranibizumab injections for diabetic macular edema and the risk of sustained elevation of intraocular pressure or the need for ocular hypotensive treatment, " JAMA Ophthalmology, vol. 133, no. 5, pp. 589-597, 2015.
57. P. A. Campochiaro, R. Channa, B. B. Berger et al., "Treatment of diabetic macular edema with a designed ankyrin repeat protein that binds vascular endothelial growth factor: a phase I/II study, " American Journal of Ophthalmology, vol. 155, no. 4, pp. 697-e2, 2013.
58. R. Simo and C. Hernandez, "Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence, " Progress in Retinal and Eye Research, vol. 48, pp. 160-180, 2015.
59. M. I. Nawaz, M. Abouammoh, H. A. Khan, A. S. Alhomida, M. F. Alfaran, and M. S. Ola, "Novel drugs and their targets in the potential treatment of diabetic retinopathy, " Medical Science Monitor, vol. 19, no. 1, pp. 300-308, 2013.
60. L. Wang, N. Wang, H. Tan, Y. Zhang, and Y. Feng, "Protective efect of a Chinese Medicine formula He-Ying-Qing-Re Formula on diabetic retinopathy, " Journal of Ethnopharmacology, vol. 169, pp. 295-304, 2015.
61. H. Huang, J. He, D. Johnson et al., "Deletion of placental growth factor prevents diabetic retinopathy and is associated with akt activation and HIF1?-VEGF pathway inhibition, " Diabetes, vol. 64, no. 1, pp. 200-212, 2015.
62. S. Babapoor-Farrokhran, K. Jee, B. Puchner et al., "Angiopoietin-like 4 is a potent angiogenic factor and a novel therapeutic target for patients with proliferative diabetic retinopathy, " Proceedings of the National Academy of Sciences of the United States, vol. 112, no. 23, pp. E3030-E3039, 2015.
63. Y. Jiang, Q. Zhang, and J. J. Steinle, "Intravitreal injection of IGFBP-3 restores normal insulin signaling in diabetic rat retina, " PLoS ONE, vol. 9, no. 4, Article ID e93788, 2014.
64. H. Huang, W. Li, J. He, P. Barnabie, D. Shealy, and S. A. Vinores, "Blockade of tumor necrosis factor alpha prevents complications of diabetic retinopathy, " Journal of Clinical& Experimental Ophthalmology, vol. 5, no. 6, article 384, 2014.
65. J. He, H. Wang, Y. Liu, W. Li, D. Kim, and H. Huang, "Blockade of vascular endothelial growth factor receptor 1 prevents infam-mation and vascular leakage in diabetic retinopathy, " Journal of Ophthalmology, vol. 2015, Article ID 605946, 11 pages, 2015.
66. Y. Chen, Y. Hu, M. Lin et al., "Terapeutic efects of PPAR? agonists on diabetic retinopathy in type 1 diabetes models, " Diabetes, vol. 62, no. 1, pp. 261-272, 2013.
67. A. C. Keech, P. Mitchell, P. A. Summanen et al., "Efect of fenofbrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial, " The Lancet, vol. 370, no. 9600, pp. 1687-1697, 2007.
68. R. Simó and C. Hernández, "Fenofbrate for diabetic retinopa-thy, " The Lancet, vol. 370, no. 9600, pp. 1667-1668, 2007.
69. N. Sharma, J. L. Ooi, J. Ong et al., "The use of fenofbrate in the management of patients with diabetic retinopathy: an evidence-based review, " Australian Family Physician, vol. 44, no. 6, pp. 367-370, 2015.
70. M. Tikhonenko, T. A. Lydic, Y. Wang et al., "Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4, " Diabetes, vol. 59, no. 1, pp. 219-227, 2010.
71. P. Sapieha, J. Chen, A. Stahl et al., "Omega-3 polyunsaturated fatty acids preserve retinal function in type 2 diabetic mice, " Nutrition and Diabetes, vol. 2, article e36, 2012.
72. N. Lois, R. V. McCarter, C. O'Neill, R. J. Medina, and A. W. Stitt, "Endothelial progenitor cells in diabetic retinopath, " Frontiers in Endocrinology, vol. 5, article 44, 2014.
73. F. Xiong, X. Du, J. Hu, T. Li, S. Du, and Q. Wu, "Altered retinal microRNA expression profles in early diabetic retinopathy: an in silico analysis, " Current Eye Research, vol. 39, no. 7, pp. 720-729, 2014.
74. M. A. Ruiz, B. Feng, and S. Chakrabarti, "Polycomb repressive complex 2 regulates MiR-200b in retinal endothelial cells: potential relevance in diabetic retinopathy, " PLoS ONE, vol. 10, no. 4, Article ID e0123987, 2015.
75. R. Mortuza, B. Feng, and S. Chakrabarti, "miR-195 regulates SIRT1-mediated changes in diabetic retinopathy, " Diabetologia, vol. 57, no. 5, pp. 1037-1046, 2014.
76. E. Di Marco, J. C. Jha, A. Sharma, J. L. Wilkinson-Berka, K. A. Jandeleit-Dahm, and J. B. de Haan, "Are reactive oxygen species still the basis for diabetic complications?" Clinical Science, vol. 129, no. 2, pp. 199-216, 2015.
77. M. Zhang, C. An, Y. Gao, R. K. Leak, J. Chen, and F. Zhang, "Emerging roles of Nrf2 and phase II antioxidant enzymes in neuroprotection, " Progress in Neurobiology, vol. 100, no. 1, pp. 30-47, 2013.
78. R. C. Taylor, G. Acquaah-Mensah, M. Singhal, D. Malhotra, and S. Biswal, "Network inference algorithms elucidate Nrf2 regulation of mouse lung oxidative stress, " PLoS Computational Biology, vol. 4, no. 8, Article ID e1000166, 2008.
79. S. M. Tan and J. B. de Haan, "Combating oxidative stress in diabetic complications with Nrf2 activators: how much is too much?" Redox Report, vol. 19, no. 3, pp. 107-117, 2014.
80. J. Jeevanandam, M. K. Danquah, S. Debnath, V. S. Meka, and Y. S. Chan, "Opportunities for nano-formulations in type 2 diabetes mellitus treatments, " Current Pharmaceutical Biotechnology, vol. 16, no. 10, pp. 853-870, 2015.
81. D. Yohan and B. D. Chithrani, "Applications of nanoparticles in nanomedicine, " Journal of Biomedical Nanotechnology, vol. 10, no. 9, pp. 2371-2392, 2014.
82. X. Cai, S. A. Sezate, S. Seal, and J. F. McGinnis, "Sustained protection against photoreceptor degeneration in tubby mice by intravitreal injection of nanoceria, " Biomaterials, vol. 33, no. 34, pp. 8771-8781, 2012.
83. X. Cai, S. Seal, and J. F. McGinnis, "Sustained inhibition of neovascularization in vldlr-/-mice following intravitreal injection of cerium oxide nanoparticles and the role of the ASK1-P38/JNK-NF-?B pathway, " Biomaterials, vol. 35, no. 1, pp. 249-258, 2014.
84. L. Kong, X. Cai, X. Zhou et al., "Nanoceria extend photoreceptor cell lifespan in tubby mice by modulation of apoptosis/survival signaling pathways, " Neurobiology of Disease, vol. 42, no. 3, pp. 514-523, 2011.
85. X. Cai, J. Yodoi, S. Seal, and J. F. McGinnis, "Nanoceria and thioredoxin regulate a common antioxidative gene network in tubby mice, " Advances in Experimental Medicine and Biology, vol. 801, pp. 829-836, 2014.
86. A. Liew and T. O'Brien, "The potential of cell-based therapy for diabetes and diabetes-related vascular complications, " Current Diabetes Reports, vol. 14, no. 3, article 469, 2014.
87. V. Marchetti, T. U. Krohne, D. F. Friedlander, and M. Fried-lander, "Stemming vision loss with stem cells, " The Journal of Clinical Investigation, vol. 120, no. 9, pp. 3012-3021, 2010.
88. Y. Huang, V. Enzmann, and S. T. Ildstad, "Stem cell-based therapeutic applications in retinal degenerative diseases, " Stem Cell Reviews and Reports, vol. 7, no. 2, pp. 434-445, 2011.
89. S. D. Schwartz, J.-P. Hubschman, G. Heilwell et al., "Embryonic stem cell trials for macular degeneration: a preliminary report, " The Lancet, vol. 379, no. 9817, pp. 713-720, 2012.
90. S. D. Schwartz, C. D. Regillo, B. L. Lam et al., "Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related macular degeneration and Stargardt's macular dystrophy: follow-up of two open-label phase 1/2 studies, " The Lancet, vol. 385, no. 9967, pp. 509-516, 2015.
91. G. C. Davey, S. B. Patil, A. O'Loughlin, and T. O'Brien, "Mesenchymal stem cell-based treatment for microvascular and secondary complications of diabetes mellitus, " Frontiers in Endocrinology, vol. 5, article 86, 2014.
92. R. Megaw and B. Dhillon, "Stem cell therapies in the management of diabetic retinopathy, " Current Diabetes Reports, vol. 14, no. 7, article 498, 2014.
93. T. Asahara, T. Murohara, A. Sullivan et al., "Isolation of putative progenitor endothelial cells for angiogenesis, " Science, vol. 275, no. 5302, pp. 964-967, 1997.
94. G. Rajashekhar, A. Ramadan, C. Abburi et al., "Regenerative therapeutic potential of adipose stromal cells in early stage diabetic retinopathy, " PLoS ONE, vol. 9, no. 1, Article ID e84671, 2014.
95. T. A. Mendel, E. B. D. Clabough, D. S. Kao et al., "Pericytes derived from adipose-derived stem cells protect against retinal vasculopathy, " PLoS ONE, vol. 8, no. 5, Article ID e65691, 2013.
96. E. R. Burnight, P. D. Hsu, D. Ochoa et al., "Using RNA-mediated genome editing to create an animal model of retinal dystrophy for analysis of in vivo CRISPR/CAS9 treatment efcacy, " Investigative Ophthalmolog y & Visual Science, vol. 56, abstract 3589, 2015, The ARVO Annual Meeting.
97. E. M. Stone, "Gene editing for gene-and cell based treatment of inherited retinal disease, " Investigative Ophthalmology & Visual Science, abstract 7, 2015, The ARVO Annual Meeting.
98. S. H. Tsang, "Personalized medicine: patient specifc stem cells, mouse models and therapy for retinal degenerations, " The ARVO Annual Meeting, Denver, Colo, USA, abstract 8, May 2015.
99. K. J. Wahlin, C. Kim, J. Maruotti et al., "Gene-edited human pluripotent stem cell derived 3D retinas for modeling photore-ceptor development and disease, " Investigative Ophthalmology & Visual Science, vol. 56, abstract 3596, 2015, The ARVO Annual Meeting.